- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic drivers of non-alcoholic fatty liver disease
Authors
Keywords
NAFLD, NASH, Obesity, Adipose tissue, Lipotoxicity, Fructose
Journal
Molecular Metabolism
Volume -, Issue -, Pages 101143
Publisher
Elsevier BV
Online
2020-12-18
DOI
10.1016/j.molmet.2020.101143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials
- (2020) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Complications, morbidity and mortality of nonalcoholic fatty liver disease
- (2020) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Visceral adipose tissue Tregs and the cells that nurture them
- (2020) Chaoran Li et al. IMMUNOLOGICAL REVIEWS
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MARC1 variant rs2642438 increases hepatic phosphatidylcholines and decreases severity of non-alcoholic fatty liver disease in humans
- (2020) Panu K. Luukkonen et al. JOURNAL OF HEPATOLOGY
- Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance
- (2020) Kay H. M. Roumans et al. Nature Communications
- A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease
- (2020) Connor A. Emdin et al. PLoS Genetics
- Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future
- (2020) Sonja Lang et al. Cell Host & Microbe
- Deletion of Fructokinase in the Liver or in the Intestine Reveals Differential Effects on Sugar-Induced Metabolic Dysfunction
- (2020) Ana Andres-Hernando et al. Cell Metabolism
- Finding the Sweet Spot: Parsing Tissue-Specific Contributions of Fructose Metabolism
- (2020) Gregory J. Tesz et al. Cell Metabolism
- Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Co-morbid Diseases
- (2020) Ethan M. Weinberg et al. Clinical Gastroenterology and Hepatology
- Insights into genetic variants associated with NASH-fibrosis from metabolite profiling
- (2020) Jake P Mann et al. HUMAN MOLECULAR GENETICS
- Adipocyte Gi signaling is essential for maintaining whole-body glucose homeostasis and insulin sensitivity
- (2020) Lei Wang et al. Nature Communications
- Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD
- (2020) Annelise M. Poss et al. Frontiers in Endocrinology
- Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems
- (2020) Trenton T. Ross et al. Cellular and Molecular Gastroenterology and Hepatology
- Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
- (2020) Theresa J. Hydes et al. Clinical and Molecular Hepatology
- Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
- (2020) Tracey G Simon et al. GUT
- Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose
- (2020) Kentaro Futatsugi et al. JOURNAL OF MEDICINAL CHEMISTRY
- New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
- (2020) Domenico Ferro et al. Nutrients
- Dysregulated lipid metabolism links NAFLD to cardiovascular disease
- (2020) Audrey Deprince et al. Molecular Metabolism
- Genetic and epigenetic factors determining NAFLD risk
- (2020) Wenke Jonas et al. Molecular Metabolism
- Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease
- (2019) Michael B. Boffa et al. Nature Reviews Cardiology
- NASH in Lean Individuals
- (2019) Ramy Younes et al. SEMINARS IN LIVER DISEASE
- Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease
- (2019) Cheng-Maw Ho et al. Journal of Inflammation-London
- Past, present and future perspectives in nonalcoholic fatty liver disease
- (2019) Arun J. Sanyal Nature Reviews Gastroenterology & Hepatology
- NAFLD in children: new genes, new diagnostic modalities and new drugs
- (2019) Valerio Nobili et al. Nature Reviews Gastroenterology & Hepatology
- Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice
- (2019) Kentaro Arakawa et al. PLoS One
- Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study
- (2019) Dong Hyun Sinn et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Lean NAFLD : A Distinct Entity Shaped by Differential Metabolic Adaptation
- (2019) Fei Chen et al. HEPATOLOGY
- THE ROLE OF THE GUT MICROBIOTA IN LIVER DISEASE
- (2019) Somaya A. M. Albhaisi et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis
- (2019) Xiaoli Sun et al. Cell Metabolism
- Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
- (2019) Mohammed Eslam et al. Nature Reviews Gastroenterology & Hepatology
- Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
- (2019) Naga Chalasani et al. GASTROENTEROLOGY
- Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
- (2019) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Intestinal Fructose and Glucose Metabolism in Health and Disease
- (2019) Beatriz Merino et al. Nutrients
- Dietary Fructose Metabolism By Splanchnic Organs: Size Matters
- (2018) Javier T. Gonzalez et al. Cell Metabolism
- The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids
- (2018) Cholsoon Jang et al. Cell Metabolism
- Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-stage Liver Disease Scores Compared With Placebo
- (2018) Catherine T. Frenette et al. Clinical Gastroenterology and Hepatology
- Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
- (2018) Eric J. Lawitz et al. Clinical Gastroenterology and Hepatology
- Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars
- (2018) Panu K. Luukkonen et al. DIABETES CARE
- The Science of Obesity Management: An Endocrine Society Scientific Statement
- (2018) George A Bray et al. ENDOCRINE REVIEWS
- Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
- (2018) Stephen A. Harrison et al. GASTROENTEROLOGY
- Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents
- (2018) Leigh Goedeke et al. HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Fructose metabolism and metabolic disease
- (2018) Sarah A. Hannou et al. JOURNAL OF CLINICAL INVESTIGATION
- Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease
- (2018) Bo Kyung Koo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
- (2018) Thomas Jensen et al. JOURNAL OF HEPATOLOGY
- Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
- (2018) Lesley Hoyles et al. NATURE MEDICINE
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
- (2018) Noura S. Abul-Husn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers
- (2018) Takahisa Kawaguchi et al. PLoS One
- Nonalcoholic Fatty Liver Disease in Children
- (2018) Jake Mann et al. SEMINARS IN LIVER DISEASE
- Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
- (2018) Alessia Di Costanzo et al. Scientific Reports
- Dietary Sugars Stimulate Fatty Acid Synthesis in Adults
- (2018) Elizabeth J. Parks et al. JOURNAL OF NUTRITION
- Nonalcoholic Fatty Liver Disease in Humans Is Associated with Increased Plasma Endotoxin and Plasminogen Activator Inhibitor 1 Concentrations and with Fructose Intake
- (2018) Sabine Thuy et al. JOURNAL OF NUTRITION
- Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice
- (2018) Xuchu Que et al. NATURE
- GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2018) Konstantin Kazankov et al. Nature Reviews Gastroenterology & Hepatology
- HSD17B13 and Chronic Liver Disease in Blacks and Hispanics
- (2018) Julia Kozlitina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic Fatty Liver Disease
- (2018) Irene Pierantonelli et al. TRANSPLANTATION
- Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis
- (2017) Fabiana de Faria Ghetti et al. EUROPEAN JOURNAL OF NUTRITION
- Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity
- (2017) Jean-Marc Schwarz et al. GASTROENTEROLOGY
- Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis
- (2017) Matthew J. Klebanoff et al. HEPATOLOGY
- Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling
- (2017) Samir Softic et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)
- (2017) Kim Huard et al. JOURNAL OF MEDICINAL CHEMISTRY
- SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology
- (2017) Hitoshi Shimano et al. Nature Reviews Endocrinology
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Childhood Adiposity and Nonalcoholic Fatty Liver Disease in Adulthood
- (2017) Yinkun Yan et al. PEDIATRICS
- Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β
- (2017) Kevin M. Hart et al. Science Translational Medicine
- Unraveling the Regulation of Hepatic Metabolism by Insulin
- (2017) Paul M. Titchenell et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients
- (2017) Franck Chiappini et al. Scientific Reports
- The intestinal barrier: a fundamental role in health and disease
- (2017) Maaike Vancamelbeke et al. Expert Review of Gastroenterology & Hepatology
- Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease
- (2016) Tim Hendrikx et al. BMC Medicine
- Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP
- (2016) Romeo Papazyan et al. Cell Metabolism
- Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease
- (2016) William N. Hannah et al. Clinics in Liver Disease
- Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
- (2016) Samir Softic et al. DIGESTIVE DISEASES AND SCIENCES
- The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
- (2016) Rosellina Margherita Mancina et al. GASTROENTEROLOGY
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Trends in Obesity Among Adults in the United States, 2005 to 2014
- (2016) Katherine M. Flegal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014
- (2016) Cynthia L. Ogden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies
- (2016) A. Katrina Loomis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ChREBP regulates fructose-induced glucose production independently of insulin signaling
- (2016) Mi-Sung Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients
- (2016) Javier Ampuero et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
- (2016) Panu K. Luukkonen et al. JOURNAL OF HEPATOLOGY
- Immunology in the liver — from homeostasis to disease
- (2016) Felix Heymann et al. Nature Reviews Gastroenterology & Hepatology
- The Role of Cholesterol in the Pathogenesis of NASH
- (2016) George N. Ioannou TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis
- (2016) Mark A. Herman et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes
- (2015) Rachel J. Perry et al. CELL
- Ethnic-Specific Criteria for Classification of Body Mass Index: A Perspective for Asian Indians and American Diabetes Association Position Statement
- (2015) Anoop Misra Diabetes Technology & Therapeutics
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
- (2015) D. Lee Gorden et al. JOURNAL OF LIPID RESEARCH
- Fructose and Cardiometabolic Health
- (2015) Vasanti S. Malik et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2015) Su Jong Yu et al. MEDICINE
- Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo
- (2015) Paul M. Titchenell et al. Nature Communications
- The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis
- (2015) Emma L. Anderson et al. PLoS One
- Lack of Efficacy of an Inhibitor of PDE4 in Phase 1 and 2 Trials of Patients With Nonalcoholic Steatohepatitis
- (2014) Vlad Ratziu et al. Clinical Gastroenterology and Hepatology
- Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans
- (2014) M. Miriam Jacome-Sosa et al. CURRENT OPINION IN LIPIDOLOGY
- PNPLA3 variant I148M is associated with altered hepatic lipid composition in humans
- (2014) Andreas Peter et al. DIABETOLOGIA
- Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials
- (2014) S Chiu et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- 379 Characteristics and Long-Term Prognosis of Lean Patients With Nonalcoholic Fatty Liver Disease
- (2014) Anna Christina Dela Cruz et al. GASTROENTEROLOGY
- No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial
- (2014) Arun J. Sanyal et al. GASTROENTEROLOGY
- Decreasing the Rate of Metabolic Ketone Reduction in the Discovery of a Clinical Acetyl-CoA Carboxylase Inhibitor for the Treatment of Diabetes
- (2014) David A. Griffith et al. JOURNAL OF MEDICINAL CHEMISTRY
- The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
- (2014) Rachel J. Perry et al. NATURE
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates
- (2013) Kylie Kavanagh et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Involvement of free radicals and oxidative stress in NAFLD/NASH
- (2013) Y. Sumida et al. FREE RADICAL RESEARCH
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- >Fructose: Where Does the Truth Lie?
- (2013) John L. Sievenpiper et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- The Gordian Knot of dysbiosis, obesity and NAFLD
- (2013) Wajahat Z. Mehal Nature Reviews Gastroenterology & Hepatology
- Sugar-Sweetened Beverages, Genetic Risk, and Obesity
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice
- (2012) Veerle Bieghs et al. HEPATOLOGY
- Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes
- (2012) Manal F. Abdelmalek et al. HEPATOLOGY
- The Mitochondrial Amidoxime-reducing Component (mARC1) Is a Novel Signal-anchored Protein of the Outer Mitochondrial Membrane
- (2012) Julian M. Klein et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease
- (2012) Roslyn Vongsuvanh et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic steatohepatitis: The role of oxidized low-density lipoproteins
- (2012) Sofie M.A. Walenbergh et al. JOURNAL OF HEPATOLOGY
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- (2012) Jorge Henao-Mejia et al. NATURE
- Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice
- (2012) T. Ishimoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages
- (2011) Veerle Bieghs et al. ATHEROSCLEROSIS
- Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects
- (2011) Sven Haufe et al. HEPATOLOGY
- A Dual Sugar Challenge Test for Lipogenic Sensitivity to Dietary Fructose
- (2011) Lisa C. Hudgins et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- No need for a large belly to have NASH
- (2011) Mariana Verdelho Machado et al. JOURNAL OF HEPATOLOGY
- Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2011) Helen M. Parker et al. JOURNAL OF HEPATOLOGY
- A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein
- (2011) Yimin et al. LABORATORY INVESTIGATION
- SREBPs: metabolic integrators in physiology and metabolism
- (2011) Tae-Il Jeon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits
- (2011) Elizabeth K. Speliotes et al. PLoS Genetics
- Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men
- (2010) H. Sobrecases et al. DIABETES & METABOLISM
- Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease
- (2010) Manal F. Abdelmalek et al. HEPATOLOGY
- Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
- (2010) Nitika Arora Gupta et al. HEPATOLOGY
- Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease
- (2010) Kausik Das et al. HEPATOLOGY
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity
- (2010) Anna Ludovica Fracanzani et al. JOURNAL OF HEPATOLOGY
- Elevated endotoxin levels in non-alcoholic fatty liver disease
- (2010) Alison L Harte et al. Journal of Inflammation-London
- Quantification of Liver Fat with Magnetic Resonance Imaging
- (2010) Scott B. Reeder et al. Magnetic Resonance Imaging Clinics of North America
- The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
- (2010) Jung Sub Lim et al. Nature Reviews Gastroenterology & Hepatology
- Fructose and metabolic diseases: New findings, new questions
- (2010) Luc Tappy et al. NUTRITION
- A feed-forward loop amplifies nutritional regulation of PNPLA3
- (2010) Yongcheng Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
- (2009) Kimber L. Stanhope et al. JOURNAL OF CLINICAL INVESTIGATION
- Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome
- (2009) Ali Abid et al. JOURNAL OF HEPATOLOGY
- Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease
- (2009) Astrid Spruss et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
- (2009) E. Fabbrini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
- (2009) Naim Alkhouri et al. Expert Review of Gastroenterology & Hepatology
- Selective versus Total Insulin Resistance: A Pathogenic Paradox
- (2008) Michael S. Brown et al. Cell Metabolism
- Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
- (2008) Rajasekhara R. Mummadi et al. Clinical Gastroenterology and Hepatology
- The Natural History of Nonalcoholic Fatty Liver Disease: Insights From Children and Mice
- (2008) Rexford S. Ahima GASTROENTEROLOGY
- Visceral fat: A key mediator of steatohepatitis in metabolic liver disease
- (2008) David van der Poorten et al. HEPATOLOGY
- Fructose consumption as a risk factor for non-alcoholic fatty liver disease
- (2008) Xiaosen Ouyang et al. JOURNAL OF HEPATOLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
- Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
- (2008) Adilson Guilherme et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started